Pennant Group, Inc. (PNTG): EBITDA
$60.42M
Year ended 2025-12-31
$72.34M
Trailing 12 months to 2026-06-30
+50.7%
3-year compound annual growth
+20.7%
5-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $60.42M | +36.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $44.23M | +46.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $30.30M | +71.8% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $17.64M | +86.1% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $9.48M | -59.8% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $23.59M | +148.9% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $9.48M | -59.8% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $23.59M | +31.5% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $17.95M | n/a | 2020-03-04, From 2017-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $60.42M | +36.6% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $23.76M | n/m |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $109.07M | +33.5% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $65.77M | +625.6% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | -$186.14M | n/m |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | -$3.48M | n/m |
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $44.14M | +82.0% |
| DocGo Inc. (DCGO) | 2025-12-31 | -$162.37M | n/m |
| Omada Health, Inc. (OMDA) | 2025-12-31 | -$6.48M | n/m |
Compare PNTG, INNV, USPH, LFST side by side · Screen every company in Services-Health Services ↗